KILL Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval
By:
Business Wire
May 22, 2025 at 21:01 PM EDT
Agilent Technologies Inc. requests that their press release NewsItemId: 20250324197742 issued March 24, 2025 “Agilent xCELLigence RTCA Instrumentation Applied in Recent FDA Approval” be removed.
Contacts
Media Contact
Naomi Goumillout
Agilent Technologies
+1.978.314.1862
naomi.goumillout@agilent.com
More News
View More
The $100 Million Tell: Following Smart Money Into DoorDash ↗
Today 7:37 EST
Via MarketBeat
Wall Street’s Sleeping Giant: Is Amazon About to Wake Up? ↗
December 02, 2025
Via MarketBeat
Checkmate in the Cloud: ServiceNow's Shopping Spree ↗
December 02, 2025
Via MarketBeat
The Contrarian Case for MSTR Amid MSCI Delisting Debacle ↗
December 02, 2025
Via MarketBeat
Tickers
MSTR
Worried About Mag 7 Concentration Risk? This ETF Could Help ↗
December 02, 2025
Recent Quotes
View More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>